Home › Atrial Fibrillation › Iowa
Atrial Fibrillation clinical trials in Iowa
8 studies for Atrial Fibrillation are looking for participants at sites in Iowa.
Cities in Iowa
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
- University of Iowa Hospitals and Clinics, Iowa City
RecruitingPhase 3
Ages 22 to 85 · All sexes · Updated Sep 30, 2026 · NCT05836987A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
- University of Iowa Hospitals and Clinics, Iowa City
Recruiting
Ages 22 and older · All sexes · Updated Sep 30, 2026 · NCT07227532Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation
- Mercy Hospital Medical Center, West Des Moines
Recruiting
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07575269Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
- University of Iowa, Iowa City
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT04088071The Fourth Left Atrial Appendage Occlusion Study
- MercyOne Iowa Heart Center, West Des Moines
Recruiting
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT05963698BOdygUardian MOnitoriNg for ReCurrencE of AF
- University of Iowa Hospitals and Clinics, Iowa City
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT07671677Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Anthos Investigative Site 9956, West Des Moines
RecruitingPhase 3
Ages 65 and older · All sexes · Updated Jul 13, 2026 · NCT05712200Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
- University of Iowa Medical Center, Iowa City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 8, 2026 · NCT03907046From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.